C-NRX

V:NRX - NurExone Biologic Inc. - https://www.nurexone.com

06:07:37 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NRX - V	1.0	0.66	·	0.69	56.0	0.68			4.2	2	13	0.67 0.68 0.65	1.14 0.55	14:33:04	Jan 30	15 min RT 2¢
TSX-V - V	1.0	0.66	·	0.69	56.0	0.68			2.5	2	4	0.67 0.68 0.65	1.14 0.55	14:33:04		15 min
NEO ATS - U						0.65	-0.03	-4.4	0.5	0	1	0.65 0.65 0.65		11:47:28		15 min
CX2 - H						0.68			0.04		1			Feb 04		15 min
MatchNOW - M						0.68			1.2	0	7					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 13

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:30:36	M	0.68		10	80 National Bank	2 RBC	E
15:05:12	M	0.68		2	7 TD Sec	7 TD Sec	E
14:33:04	M	0.68		383	80 National Bank	1 Anonymous	E
14:33:04	V	0.68		500	80 National Bank	7 TD Sec	K
14:31:09	V	0.65	-0.03	23	36 Latimer	39 Merrill Lynch
14:31:09	V	0.65	-0.03	1,000	84 ITG84	39 Merrill Lynch	K
14:02:04	M	0.68		30	80 National Bank	1 Anonymous	E
11:47:28	U	0.65	-0.03	500	13 Instinet	88 Credential	K
10:55:29	M	0.68		290	80 National Bank	1 Anonymous	E
10:16:57	M	0.68		290	80 National Bank	1 Anonymous	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2026-01-30 17:29	C:NRX	0.66	News Release200	Nurexone Biologic appoints Gabbai director
2025-12-19 16:04	C:NRX	0.69	News Release200	NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
2025-12-12 17:02	C:NRX	0.61	News Release200	Nurexone prepares small-scale manufacturing for ExoPTEN
2025-11-28 09:15	C:NRX	0.71	News Release200	NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-26 17:18	C:NRX	0.71	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-11-26 17:12	C:NRX	0.71	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-11-12 22:03	C:NRX	0.70	News Release200	Nurexone receives $3.18-million from warrant exercise
2025-11-04 02:56	C:NRX	0.69	News Release200	Nurexone joins BioFab Startup Lab
2025-10-21 16:04	C:NRX	0.78	News Release200	NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
2025-10-08 18:27	C:NRX	0.90	News Release200	Nurexone shows vision recovery in glaucoma study
2025-09-17 20:52	C:NRX	1.07	Private Placement250	Nurexone Biologic 930,376-share private placement
2025-09-17 04:55	C:NRX	1.05	News Release200	Nurexone to open exosome production facility in Indiana
2025-09-12 01:22	C:NRX	0.90	News Release200	Nurexone Biologic receives patent in Israel
2025-09-09 21:06	C:NRX	0.84	Private Placement250	Nurexone Biologic 1,258,072-share private placement
2025-09-08 16:30	C:NRX	0.81	News Release200	NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
2025-08-28 08:15	C:NRX	0.83	News Release200	NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results
2025-08-20 19:36	C:NRX	0.79	News Release200	Nurexone releases preclinical ExoPTEN imaging results
2025-08-08 17:30	C:NRX	0.69	News Release200	Nurexone says exosomes beat industry healing standard
2025-07-08 16:24	C:NRX	0.67	News Release200	New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
2025-06-20 10:16	C:NRX	0.67	News Release200	Nurexone Biologic joins HealthTech Hub program

Date ET

Symbol

Price

Type

Headline

2026-01-30 17:29

C:NRX

0.66

News Release

Nurexone Biologic appoints Gabbai director

2025-12-19 16:04

C:NRX